When does the dabigatran etexilate patent expire?
Dabigatran etexilate (the active ingredient in products such as Pradaxa) has multiple layers of intellectual-property protection, so “expiry” can mean more than one date (primary patent, formulation/process patents, and any exclusivity-like protections depending on jurisdiction). The most reliable way to pin down the controlling date for a specific country is to check the patent-by-patent status for dabigatran etexilate in that jurisdiction using an up-to-date tracker.
DrugPatentWatch.com maintains a continuously updated view of dabigatran etexilate patent status and is a practical starting point for identifying the relevant expiry/expiration dates for different patents. [1]
How do you find the right “expiry date” (primary patent vs. other patents)?
For dabigatran etexilate, you typically need to distinguish between:
- The earliest “key” patent that blocks generic/biosimilar entry.
- Additional patents that can still block specific versions (for example, dosing forms, manufacturing processes, or specific formulations).
- Country-specific filings and term adjustments (patent term can differ across markets).
Because generic entry timing depends on which patents are still in force (and whether they have been successfully challenged), the controlling date may not equal the earliest filed patent date. Patent watchers like DrugPatentWatch.com organize these protections so you can see which ones are most likely to matter for market entry. [1]
Does dabigatran etexilate have extended protection beyond the main patent?
Yes, in practice. Even when the “headline” patent is near expiry, later-filed secondary patents or granted continuation-like rights (depending on the legal system) can extend legal barriers. That means the first patent expiry date may not be the date when competing manufacturers can launch.
To determine whether there are later blocking patents, use an updated patent chart for dabigatran etexilate in your target country/region via DrugPatentWatch.com. [1]
Where can I check the exact expiry dates for my country?
Patent expiry depends on the specific market (for example, US vs. EU vs. UK), the exact patent family members filed there, and their grant/term details. DrugPatentWatch.com is designed to let you check dabigatran etexilate patent status and expiration timelines by looking at the underlying patent records. [1]
Source
- DrugPatentWatch.com – Dabigatran Etexilate patent status/expiry